Novonesis (Novozymes) B (WBO:NZYM)
€ 57.3 -0.28 (-0.49%) Market Cap: 26.58 Bil Enterprise Value: 28.31 Bil PE Ratio: 39.43 PB Ratio: 2.43 GF Score: 93/100

Q3 2020 Novozymes A/S Earnings Call Transcript

Oct 21, 2020 / 07:00AM GMT
Release Date Price: €54.1 (-2.80%)
Tobias Cornelius Bjorklund;S;Head of IR
Novozymes A

/-

Thank you, operator, and welcome, everyone. Thank you for joining us. My name is Tobias Bjorklund, and I'm the Head of Investor Relations at Novozymes.

At this call, Ester Baiget, CEO of Novozymes; and Lars Green, our CFO, will go through our performance for the first 9 months of 2020, the outlook for the full year and comment on the recent changes to our organizational setup. We expect the presentation to take roughly 20 minutes. After which, we will open up for questions.

Also with us today, we have the rest of the management team, namely: Anders Lund, EVP Consumer Biosolutions; Tina Fanø, EVP Industrial Biosolutions; Thomas Videbaek, Interim EVP of Strategy and Business Transformation as well as People, Sustainability and Brand; Claus Fuglsang, Chief Science Officer; and Graziela Malucelli, Chief of Operations. We expect the entire call to take 50 minutes.

Before we begin, I would like to remind you that the information presented at the call is unaudited and that management may make

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot